Equities research analysts at Zacks Research lowered their Q2 2025 earnings estimates for Elevance Health in a research ...

Health insurance provider Elevance Health (NYSE:EVH) in Q4 CY2024, with sales up 6.6% year on year to $45.44 billion. Its non ...

After a dip in the wake of the release of UnitedHealth Group's Q4 2024 earnings figures, shares in the company and other ...

Q4 2024 Earnings Call Transcript January 23, 2025 Elevance Health Inc. beats earnings expectations. Reported EPS is $3.84, ...

Barclays raised the firm’s price target on Elevance Health (ELV) to $512 from $501 and keeps an Overweight rating on the shares post the Q4 ...

Mizuho Securities analyst Ann Hynes has maintained their bullish stance on ELV stock, giving a Buy rating on January 16.Invest with ...

Elevance Health (NYSE: ELV) Q4 2024 Earnings Call Jan 23, 2025, 8:30 a.m. ET ...

Medicaid managed care organizations, including Elevance Health, Centene and UnitedHealth Group, are working with states to secure rates that account for sicker patients.

Elevance Health reported stronger-than-expected results and raised its dividend as it benefited from higher premiums, acquisitions, and growth in its pharmacy division.

Elevance Health Q4 revenues hit $45 billion, driven by premium growth and acquisitions. 2025 EPS guidance is $34.15-$34.85, with a $1.71 dividend declared.

The company posted adjusted earnings per share of $3.84 for Q4 2024, falling short of the $3.98 consensus estimate. Revenue ...

The Indianapolis-based company said it had net income of $1.81 per share. Earnings, adjusted for one-time gains and costs, came to $3.84 per share. The results beat Wall Street expectations. The ...